News of Licenses | Approvals | Permissions in Gujarat

NCLT nods demerger of Tyre biz from KESORAM INDUSTRIES

KOLKOTTA | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Kolkata headquartered Kesoram Industries Ltd said of having got National Company Law Tribunal (NCLT) nod to demerge tyre business from the parent company. The company statement as submitted to the Indian Bourses, alongwith press-release titled, “NCLT approves

GLENMARK PHARMA gets USFDA nod to market skin & pimple care treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food & Drugs Administration) to market skin & pimple care treatment. The press-release as submitted by the company to the Indian Bourses – titled, “Glenmark

STRIDES PHARMA : USFDA announces Lab testing & analysis of Ranitidine Tablets

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Pharma company Strides Pharma Science Ltd said of having its Rantidine Tablets tested by USFDA and the regulator has announced testing & analysis results of the company terming as NDMA (nitrosodimethylamine) levels with acceptable limits. The company

USFDA slams Form 483 to ALKEM LAB’s Daman plant, clears Baddi (HP) facility

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Exchanges, Mumbai headquartered pharma company Alkem Laboratories Ltd said of its Baddi (Himachal Pradesh) and Daman plants having inspected by USFDA (US Food and Drugs Administration) in month of August 2019, the regulators have given Establishment Inspection Report (EIR) to the

LUPIN gets USFDA nod to market medicine to cure Thyroid

BALTIMORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges by Lupin Ltd, the company said of having got approval from USFDA (US Food & Drugs Administration) to market medicine to cure thyroid and thyroid related diseases. The company release as submitted to the Indian Bourses read that,

INDOCO REMIDIES gets USFDA nod to market medicine to treat acidity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Indoco Remedies Ltd said of having got approval from USFDA (US Food & Drugs Administration) to market medicine, to treat acidity and gastric secretions. The press-release as submitted by the company to the Indian Bourses,

LUPIN gets USFDA nod to market drug to treat THYROID

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Lupin Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat Thyroid and related disorders. In a press-release as submitted by the company to the Indian Bourses, titled –

USFDA inspects & clears UNICHEM LAB’s newly constructed KOLHAPUR facility

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company Unichem Laboratories Ltd said of its Kolhapur (Maharashtra) unit being inspected and cleared by the US FDA (Food & Drugs Administration) without any observations issued by the regulators vide Form 483. The company-update as submitted

USFDA issues warning, initiates official action against LUPIN’s Mandideep unit

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma major Lupin Ltd said of US FDA (Food & Drugs Administration) having issued warning letter and initiated official action against Mandideep facility of the company. The company update as submitted to the Indian Bourses read

LUPIN gets nod to sell HIGH BLOOD-PRESSURE treatment tablets in CANADA

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Lupin Ltd said of having got nod from Canadian Pharma Regulator – Health Canada, to market tablets to treat high blood-pressure. In a press-release as addressed to the Indian Bourses titled – “Lupin Receives Health Canada

UK REGULATORS reinstate full GMP status for INDOCO REMEDIES’ Goa plant

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Indoco Remedies Ltd said of full GMP (Good Manufacturing Practice) status being reinstated at Indoco Remedies Ltd’s Goa plant. In a press-communication as addressed by the company to the Indian Bourses titled – “UK-MHRA reinstates

LUPIN gets USFDA nod to market drug to treat Heart, Liver & Kidney disorders

BALTIMORE (US) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Lupin Ltd said of having got USFDA nod to market drug to treat heart, liver and kidney related disorders. In a press-communication submitted to the Indian Bourses, titled – “Lupin receives U.S.

GLENMARK PHARMA gets USFDA nod to market SKIN-TREATMENT product

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having got final approval from US FDA (Food & Drugs Administration) to sell dermatology (skin-treatment) product. The press-release as submitted by the company to the Indian Stock Exchanges – titled, “Glenmark Pharmaceuticals

BALAJI AMINES’ subsidiary completed EU regulatory process for ethylenediamine

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, speciality chemicals company Balaji Amines Ltd said of one of its subsidiary company having completed REACH registration process for ethylenediamine. The press-statement submitted by the company to the Indian Bourses read that, Balaji Speciality Chemicals Pvt. Ltd., Subsidiary of

UNICHEM LABS gets USFDA nod to market URINARY disorder treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Unichem Laboratories Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat urinary disorders. The company statement submitted to the Indian Bourses read that, Unichem Laboratories Limited is pleased to

STRIDES PHARMA acquires USFDA approved manufacturing facility in the US

BENGALURU | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Bengaluru & Mumbai headquartered Indian Pharma Major, Strides Pharma Science Ltd said of having acquired US FDA (Food & Drugs Admininstration) approved manufacturing facility at Riviera Beach (Florida) in The United State of America. The press-release as

Do NOT follow this link or you will be banned from the site!